Category: Approval/Launch Region: North America · United States Company: Abk Biomedical Inc

Us Fda Clears Abk Biomedicals Easi Vue Embolic Microspheres For Embolization Of Arteriovenous Malformations And Hypervascular Tumours

Us Fda Clears Abk Biomedicals Easi Vue Embolic Microspheres For Embolization Of Arteriovenous Malformations And Hypervascular Tumours
Abk Biomedical, Inc., An Innovative Medical Device Company, Announces Fda 510(K) Clearance Of Easi-Vue Embolic Microspheres For The Treatment Of Patients Suffering From Arteriovenous Malformations And Hypervascular Tumours.Arteriovenous Malformations (Avms) Occur When Capillaries, Veins, And Arteries Don

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!